- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04063228
High Level Mobility Training in Ambulatory Patients With Acquired Non-progressive Central Neurological Injury
August 7, 2020 updated by: NYU Langone Health
Brain injuries are a significant cause of loss of movement.
It has been shown that physical therapy can help patients to regain movements.
The purpose of this study is to see if it is possible to perform a new exercise program that will help patients regain movement.
This new exercise program will involve practicing walking, stairs, jumping and running.
Participation in this study will involve physical therapy 1 to 2 times a week for 12 visits over 6 to 8 weeks.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Referred to physical therapy with an Acquired Non-Progressive Central Neurological Injury (traumatic brain injury, stroke, brain tumor, spinal cord injury) for 3 months or more
- capacity to consent
- ability to read and write English at the sixth grade level
- able to walk twenty meter without physical assistance or an assistive device, however they can use a brace.
- self-selected gait speed of 0.6 m/s or greater when performing 10 meter walk test.
Exclusion Criteria:
- Adults subjects diagnosed with a progressive central or peripheral neurological disorder or an acute non progressive central neurological disorder (less than 3 months)
- Subjects who require physical assistance or an assistive device to walk twenty meters or demonstrate self-selected gait speed less than 0.6 m/s
- Subjects who are already able to run independently in the community
- Participants who are unable to complete the 12 physical therapy visits at prescribed skill level as established by protocol
- Participants who reports >4/10 on NPRS with lower extremity weight bearing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Standard of care
|
will practice the following skills as needed: bed mobility, transfer, walking, and stairs.
|
|
ACTIVE_COMPARATOR: Simple Skill Group
|
The program will consist of interventions at the impairments level with an emphasis on core strengthening, functional lower extremity strengthening, balance and endurance training, and at the skill acquisition level.
Participants will learn pre-running skills (walking, stairs with handrail, walking backward, walking over obstacles, walking on toes, stairs without handrail, bounding), running skills (force generation in vertical plane: hopping, alternate hopping, running in place in gravity minimized position and against gravity; force generation in horizontal plane: bounding, alternate bounding, open chain movement for swing phase, running) and post running skills (running forward, backward, sideways, skipping, hopping).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Feasibility
Time Frame: 2 Years
|
measured by the number of individuals who consent to participate.
|
2 Years
|
|
Training feasibility
Time Frame: 2 Years
|
Measured by the number of sessions attended by each participant.
|
2 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Estelle Gallo, MD, New York Langone Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 17, 2019
Primary Completion (ACTUAL)
June 1, 2020
Study Completion (ACTUAL)
June 1, 2020
Study Registration Dates
First Submitted
August 19, 2019
First Submitted That Met QC Criteria
August 19, 2019
First Posted (ACTUAL)
August 21, 2019
Study Record Updates
Last Update Posted (ACTUAL)
August 11, 2020
Last Update Submitted That Met QC Criteria
August 7, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-00695
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Injury
-
Massachusetts General HospitalRecruitingEmotional Distress | Acute Neurological InjuryUnited States
-
Madonna Rehabilitation HospitalActive, not recruitingNeurological Injury | Neurological Diseases or ConditionsUnited States
-
Washington University School of MedicineAstellas Pharma IncCompletedThis Study is to Understand the Current Practice of Sodium Management in Acute Neurological InjuryUnited States
-
Assaf-Harofeh Medical CenterAriel UniversityTerminatedResponse of the Cardiac Autonomic Control System After Oxygen Therapy 100% in Hyperbaric EnvironmentNeurological InjuryIsrael
-
The University of Texas Health Science Center,...CompletedSpinal Cord InjuriesUnited States
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Duke UniversityAbbottCompletedBrain Injuries, Traumatic | Enteral Nutrition | ICU AdmissionUnited States
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeCompletedAcute Kidney Injury | Neurological InjurySingapore
-
Paul G. Harch, M.D.Harch Hyperbaric Research FoundationUnknownResidual Neurological, Cognitive, Emotional, Behavioral Effects From Traumatic Brain InjuryUnited States
-
NYU Langone HealthCompletedHemiplegia | Neurological InjuryUnited States
Clinical Trials on Simple Skill Group
-
National Taiwan University HospitalCompletedAutism Spectrum DisorderTaiwan
-
University of OsloCompleted
-
University of Southern CaliforniaCalifornia Department of Public HealthRecruitingCaregiver Burden of People With DementiaUnited States
-
NYU Langone HealthCompletedHeart FailureUnited States
-
Fatima Jinnah Women UniversityCompletedQuality of Life | Psychological Distress | Mental Health Issue | Well-Being, PsychologicalPakistan
-
King Edward Medical UniversityNot yet recruiting
-
Cristina García-BravoCompletedMultiple Sclerosis
-
Chinese University of Hong KongCompletedObstructive Sleep ApneaChina
-
National Cheng-Kung University HospitalRecruitingVirtual Reality | Geriatric | Hand Mirror | Kinesiology, AppliedTaiwan
-
University Hospital, Clermont-FerrandRecruitingBipolar Disorder Type I or II (According to DSM-5)France